TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) has issued an update.
Shanghai Haohai Biological Technology Co., Ltd. has announced a final cash dividend of RMB 0.6 per share for the financial year ending December 31, 2024, with the payment date set for July 18, 2025. The dividend will be paid in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.091715, and the withholding tax rates will vary depending on the residency status of the shareholders, impacting non-resident and resident shareholders differently.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. operates in the biotechnology industry, focusing on the development and production of biological materials and products. The company is known for its innovative solutions in healthcare, particularly in the fields of ophthalmology, orthopedics, and medical aesthetics.
Average Trading Volume: 698,022
Technical Sentiment Signal: Sell
Current Market Cap: HK$11.93B
Learn more about 6826 stock on TipRanks’ Stock Analysis page.